| Soluble markers of inflammation and coagulation but not T-cell activation predict non–AIDS-defining morbid events during suppressive antiretroviral treatment AR Tenorio, Y Zheng, RJ Bosch, S Krishnan, B Rodriguez, PW Hunt, ... The Journal of infectious diseases 210 (8), 1248-1259, 2014 | 610 | 2014 |
| An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia SM Dillon, EJ Lee, CV Kotter, GL Austin, Z Dong, DK Hecht, S Gianella, ... Mucosal immunology 7 (4), 983-994, 2014 | 524 | 2014 |
| On the Future of Argo: A Global, Full-Depth, Multi-Disciplinary Array D Roemmich, MH Alford, H Claustre, K Johnson, B King, J Moum, P Oke, ... Frontiers in Marine Science 6, 439, 2019 | 319 | 2019 |
| Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction M D’Souza, AP Fontenot, DG Mack, C Lozupone, S Dillon, A Meditz, ... The Journal of Immunology 179 (3), 1979-1987, 2007 | 319 | 2007 |
| Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity AC Stubbs, KS Martin, C Coeshott, SV Skaates, DR Kuritzkes, D Bellgrau, ... Nature medicine 7 (5), 625-629, 2001 | 283 | 2001 |
| Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by … T Tuting, CC Wilson, DM Martin, YL Kasamon, J Rowles, DI Ma, ... The Journal of Immunology 160 (3), 1139-1147, 1998 | 270 | 1998 |
| Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1–infected individuals MA Barron, N Blyveis, BE Palmer, S MaWhinney, CC Wilson The Journal of infectious diseases 187 (1), 26-37, 2003 | 263 | 2003 |
| Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infection SM Dillon, EJ Lee, CV Kotter, GL Austin, S Gianella, B Siewe, DM Smith, ... Mucosal immunology 9 (1), 24-37, 2016 | 201 | 2016 |
| Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) B Taiwo, L Zheng, S Gallien, RM Matining, DR Kuritzkes, CC Wilson, ... Aids 25 (17), 2113-2122, 2011 | 189 | 2011 |
| Functional and phenotypic characterization of CD57+ CD4+ T cells and their association with HIV-1-induced T cell dysfunction BE Palmer, N Blyveis, AP Fontenot, CC Wilson The Journal of Immunology 175 (12), 8415-8423, 2005 | 188 | 2005 |
| The gut microbiome and HIV-1 pathogenesis: a two-way street SM Dillon, DN Frank, CC Wilson Aids 30 (18), 2737-2751, 2016 | 177 | 2016 |
| Association of functional impairment with inflammation and immune activation in HIV type 1–infected adults receiving effective antiretroviral therapy KM Erlandson, AA Allshouse, CM Jankowski, EJ Lee, KM Rufner, ... The Journal of infectious diseases 208 (2), 249-259, 2013 | 175 | 2013 |
| Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1 CC Wilson, D McKinney, M Anders, S MaWhinney, J Forster, C Crimi, ... The Journal of Immunology 171 (10), 5611-5623, 2003 | 148 | 2003 |
| Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation SM Dillon, J Kibbie, EJ Lee, K Guo, ML Santiago, GL Austin, S Gianella, ... Aids 31 (4), 511-521, 2017 | 142 | 2017 |
| Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection A Kassu, RA Marcus, MB D’Souza, EA Kelly-McKnight, L Golden-Mason, ... The Journal of Immunology 185 (5), 3007-3018, 2010 | 135 | 2010 |
| Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection SM Dillon, KB Robertson, SC Pan, S Mawhinney, AL Meditz, JM Folkvord, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 48 (1), 1-12, 2008 | 133 | 2008 |
| Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes CC Wilson, B Palmer, S Southwood, J Sidney, Y Higashimoto, E Appella, ... Journal of virology 75 (9), 4195-4207, 2001 | 133 | 2001 |
| Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo KJ Lavender, K Gibbert, KE Peterson, E Van Dis, S Francois, T Woods, ... Journal of virology 90 (13), 6001-6013, 2016 | 127 | 2016 |
| Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function BE Palmer, E Boritz, CC Wilson The Journal of Immunology 172 (5), 3337-3347, 2004 | 124 | 2004 |
| Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection CM Hay, DJ Ruhl, NO Basgoz, CC Wilson, JM Billingsley, ... Journal of virology 73 (7), 5509-5519, 1999 | 121 | 1999 |
